Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001103780-16-000076

CEO bought 20,000 shares at an average $0.17 ($3,325)

From the SEC's structured data for this filing

Trades in this filing

BUNKA CHRISTOPHER · CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2016-01-04 Purchase : show line 1 in the form +5,000 $0.16 $775 4,942,854 I
2016-01-04 Purchase : show line 2 in the form +10,000 $0.17 $1,650 4,952,854 I
2016-01-04 Purchase : show line 3 in the form +5,000 $0.18 $900 4,957,854 I
Open-market purchases · 20,000 sh · avg $0.17 · $3,325
Loading xslF345X03/primary_doc.xml…